glp-1 alzheimer's clinical trials Disappointing Results in Trial: Underscores Promise (and Limits) of Single-Agent Approaches Older GLP-1 drug may help

(PubMed) McMillan M, Spinks EA, Fenwick GR

The aim should be to achieve adequate folate status using the most appropriate form and dose for the individual, guided wherever possible by biomarkers such as homocysteine and the wider clinical picture, rather than assuming that increasing folate intake indefinitely will produce greater health benefits

EBMT, Paris, France, 2011

This aggressive PDA is caused by inducing epithelial-mesenchymal transition (EMT) and upregulating matrix metalloprotease-2 (MMP-2) expression to enhance the motility of PDAC cells (Zelenko et al., 2016

Glucagon-like peptide-1 (GLP-1) is a hormone that helps regulate blood sugar, appetite, and digestion